CD19 and psoriasis: Although it was previously shown that therewas an increased proportion of CD44+ inflammatory and endothelial cells in PBMCs inpsoriasis vulgaris skin lesions than in non-lesion areas (24), we found no difference in the ratio of CD19+CD44+ B cellsbetween erythrodermic psoriasis skin lesions and non-lesions.